as 06-28-2024 4:00pm EST
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | SKILLMAN |
Market Cap: | 36.0B | IPO Year: | 2023 |
Target Price: | $22.91 | AVG Volume (30 days): | 24.0M |
Analyst Decision: | Buy | Number of Analysts: | 14 |
Dividend Yield: | 4.40% | Dividend Payout Frequency: | Quarterly |
EPS: | 0.78 | EPS Growth: | -33.33 |
52 Week Low/High: | $17.75 - $26.66 | Next Earning Date: | 07-18-2024 |
Revenue: | $15,486,000,000 | Revenue Growth: | 1.80% |
Revenue Growth (this year): | 3.5% | Revenue Growth (next year): | 3.42% |
KVUE Breaking Stock News: Dive into KVUE Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Argus Research
9 days ago
Argus Research
9 days ago
Simply Wall St.
12 days ago
The Wall Street Journal
19 days ago
Business Wire
a month ago
Morningstar Research
a month ago
Business Wire
2 months ago
The information presented on this page, "KVUE Kenvue Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.